Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 5 | 2026 | 171 | 2.100 |
Why?
|
| Uterine Cervical Neoplasms | 8 | 2025 | 135 | 1.310 |
Why?
|
| Survival Analysis | 2 | 2025 | 197 | 1.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2026 | 323 | 0.840 |
Why?
|
| Electronic Health Records | 4 | 2025 | 719 | 0.710 |
Why?
|
| Papillomavirus Infections | 5 | 2025 | 144 | 0.690 |
Why?
|
| Prevalence | 3 | 2018 | 830 | 0.600 |
Why?
|
| Primary Health Care | 4 | 2025 | 729 | 0.560 |
Why?
|
| Confidentiality | 1 | 2018 | 23 | 0.550 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 70 | 0.540 |
Why?
|
| Statistics as Topic | 1 | 2018 | 57 | 0.540 |
Why?
|
| Papillomaviridae | 6 | 2025 | 61 | 0.540 |
Why?
|
| Opioid-Related Disorders | 3 | 2025 | 185 | 0.530 |
Why?
|
| Computer Simulation | 3 | 2026 | 85 | 0.500 |
Why?
|
| Humans | 24 | 2026 | 17622 | 0.440 |
Why?
|
| Likelihood Functions | 2 | 2025 | 45 | 0.390 |
Why?
|
| Cluster Analysis | 2 | 2026 | 90 | 0.360 |
Why?
|
| Early Detection of Cancer | 4 | 2025 | 559 | 0.360 |
Why?
|
| Cervical Intraepithelial Neoplasia | 3 | 2022 | 16 | 0.340 |
Why?
|
| Opiate Substitution Treatment | 3 | 2025 | 55 | 0.330 |
Why?
|
| Algorithms | 2 | 2025 | 227 | 0.320 |
Why?
|
| Female | 20 | 2025 | 12715 | 0.300 |
Why?
|
| Incidence | 4 | 2020 | 1278 | 0.280 |
Why?
|
| Buprenorphine | 2 | 2025 | 53 | 0.270 |
Why?
|
| Colposcopy | 2 | 2025 | 6 | 0.260 |
Why?
|
| Middle Aged | 15 | 2025 | 7954 | 0.250 |
Why?
|
| Regression Analysis | 2 | 2025 | 268 | 0.240 |
Why?
|
| Smoking | 3 | 2020 | 420 | 0.240 |
Why?
|
| Adult | 13 | 2025 | 7621 | 0.230 |
Why?
|
| Data Interpretation, Statistical | 1 | 2026 | 69 | 0.230 |
Why?
|
| Risk Assessment | 3 | 2019 | 1093 | 0.230 |
Why?
|
| Aged | 13 | 2025 | 6223 | 0.230 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2025 | 10 | 0.230 |
Why?
|
| Data Accuracy | 1 | 2025 | 26 | 0.230 |
Why?
|
| Linear Models | 1 | 2026 | 204 | 0.230 |
Why?
|
| Risk Factors | 6 | 2025 | 3291 | 0.230 |
Why?
|
| Papillomavirus Vaccines | 1 | 2025 | 114 | 0.210 |
Why?
|
| Research Design | 1 | 2026 | 337 | 0.200 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 13 | 0.180 |
Why?
|
| Diabetes Mellitus | 1 | 2025 | 452 | 0.170 |
Why?
|
| Borrelia burgdorferi | 1 | 2020 | 1 | 0.170 |
Why?
|
| Lyme Disease | 1 | 2020 | 4 | 0.170 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 13 | 0.170 |
Why?
|
| Telephone | 1 | 2021 | 159 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 402 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 33 | 0.160 |
Why?
|
| Patient Participation | 1 | 2021 | 124 | 0.160 |
Why?
|
| Prognosis | 2 | 2019 | 609 | 0.160 |
Why?
|
| United States | 7 | 2025 | 3922 | 0.160 |
Why?
|
| Male | 10 | 2025 | 10014 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 1976 | 0.160 |
Why?
|
| Cancer Survivors | 1 | 2020 | 115 | 0.150 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 18 | 0.140 |
Why?
|
| Gastrectomy | 1 | 2018 | 46 | 0.140 |
Why?
|
| Mass Screening | 3 | 2022 | 693 | 0.140 |
Why?
|
| Human Papillomavirus DNA Tests | 1 | 2018 | 1 | 0.140 |
Why?
|
| Cervix Uteri | 1 | 2018 | 5 | 0.140 |
Why?
|
| Stomach Neoplasms | 1 | 2018 | 42 | 0.140 |
Why?
|
| Sampling Studies | 1 | 2018 | 43 | 0.140 |
Why?
|
| Telemedicine | 1 | 2021 | 196 | 0.140 |
Why?
|
| Inpatients | 1 | 2018 | 78 | 0.140 |
Why?
|
| Biomarkers | 2 | 2019 | 302 | 0.140 |
Why?
|
| Logistic Models | 2 | 2017 | 866 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 20 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 46 | 0.130 |
Why?
|
| Public Health Surveillance | 1 | 2017 | 42 | 0.130 |
Why?
|
| Health Surveys | 1 | 2018 | 242 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2017 | 54 | 0.130 |
Why?
|
| Occupations | 1 | 2016 | 15 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 158 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2017 | 53 | 0.120 |
Why?
|
| Occupational Exposure | 1 | 2016 | 66 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2016 | 57 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2016 | 40 | 0.120 |
Why?
|
| Lung | 1 | 2016 | 57 | 0.120 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 3 | 0.110 |
Why?
|
| Indians, North American | 1 | 2014 | 48 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 7 | 0.110 |
Why?
|
| Vaginal Smears | 3 | 2022 | 48 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 248 | 0.110 |
Why?
|
| Young Adult | 3 | 2025 | 2538 | 0.100 |
Why?
|
| European Continental Ancestry Group | 1 | 2016 | 470 | 0.100 |
Why?
|
| African Americans | 1 | 2016 | 429 | 0.100 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 1295 | 0.100 |
Why?
|
| Mammography | 1 | 2014 | 173 | 0.100 |
Why?
|
| Heart Failure | 1 | 2017 | 414 | 0.090 |
Why?
|
| Sex Factors | 2 | 2025 | 599 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 689 | 0.070 |
Why?
|
| Osteoporosis | 1 | 2008 | 75 | 0.070 |
Why?
|
| Fractures, Bone | 1 | 2008 | 93 | 0.070 |
Why?
|
| Adolescent | 2 | 2025 | 3625 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 302 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1005 | 0.060 |
Why?
|
| Triage | 2 | 2016 | 24 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2025 | 2502 | 0.060 |
Why?
|
| Narcotic Antagonists | 1 | 2025 | 23 | 0.060 |
Why?
|
| Nursing Care | 1 | 2024 | 4 | 0.060 |
Why?
|
| Probability | 2 | 2019 | 70 | 0.050 |
Why?
|
| Massachusetts | 1 | 2024 | 59 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 346 | 0.050 |
Why?
|
| Videoconferencing | 1 | 2021 | 7 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 23 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 1 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2020 | 3 | 0.040 |
Why?
|
| Gene Library | 1 | 2020 | 4 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 2502 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 92 | 0.040 |
Why?
|
| California | 2 | 2017 | 2433 | 0.040 |
Why?
|
| Mice | 1 | 2020 | 82 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 380 | 0.040 |
Why?
|
| Mutation | 1 | 2020 | 133 | 0.040 |
Why?
|
| Vaccination | 1 | 2025 | 726 | 0.040 |
Why?
|
| Animals | 1 | 2020 | 285 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 492 | 0.040 |
Why?
|
| Survival | 1 | 2019 | 5 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 831 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2018 | 135 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 224 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2017 | 8 | 0.030 |
Why?
|
| Papanicolaou Test | 1 | 2017 | 38 | 0.030 |
Why?
|
| Creatinine | 1 | 2017 | 65 | 0.030 |
Why?
|
| Kidney | 1 | 2017 | 52 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2017 | 92 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 2016 | 3 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 80 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 237 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 66 | 0.030 |
Why?
|
| Spirometry | 1 | 2016 | 59 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 1 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2014 | 6 | 0.030 |
Why?
|
| Metabolomics | 1 | 2014 | 9 | 0.030 |
Why?
|
| Isoflavones | 1 | 2014 | 14 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2014 | 10 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 46 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 6 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 14 | 0.030 |
Why?
|
| Obesity | 1 | 2020 | 821 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2014 | 128 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 686 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 874 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 1157 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1251 | 0.020 |
Why?
|
| Korea | 1 | 2008 | 9 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2008 | 54 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 527 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 1296 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2008 | 959 | 0.010 |
Why?
|
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->